SAN DIEGO, CA, October 9, 2017 -- Nielsen BioSciences, Inc., a privately held biopharmaceutical company based in San Diego, announces the appointment of David P. Burney, Ph.D., MBA as President and Chief Operating Officer, effective October 15, 2017. Dr. Burney joins Nielsen BioSciences with more than 20 years’ executive experience in the pharmaceutical industry with specific experience in biologics manufacturing, quality and regulatory functions. Dr. Burney is familiar with Nielsen BioSciences having served as Vice President and Chief Operating Officer of Greer Laboratories, Inc., and having been a shareholder in Nielsen BioSciences since its spin-off from an affiliated entity of Greer Laboratories in 2013.
Dr. Burney has a proven track record of performance with extensive cGMP, FDA and compliance experience in biologics and sterile products. Most recently, he served as Vice President of Quality Operations at Biotest Pharmaceutical Corp. in Boca Raton, Florida, where he managed all aspects of quality for a manufacturer of plasma derived biological sterile drugs. In prior experience at Greer Laboratories, he managed the Quality, Manufacturing and Regulatory Affairs Departments for allergenic extracts. Dr. Burney holds a Ph.D. in Chemistry from the University of Memphis and an MBA from Ashland University.
Speaking on behalf of Nielsen BioSciences' Board of Directors, David E. Thomas, Chairman, said: “We are delighted to welcome Dr. Burney aboard. The entire Nielsen Board of Directors is very familiar with David. He served our predecessor companies, Greer Laboratories and Allermed, as a senior executive since 2010. We believe his prior experience and deep understanding of our industry and our business will continue to enhance Nielsen BioSciences’ core competencies of developing and commercializing antigen-based products.”
“I have known and followed Nielsen BioSciences since its inception and am excited to join the team as President and COO. I am enthusiastic about the opportunities to build upon the current accomplishments and to continue to grow the business,” said Burney.
The following third-party website was provided for your convenience, and Nielsen BioSciences, Inc. does not endorse, verify, or otherwise support the information contained in these websites. You are subject to the legal terms and conditions of use for third-party websites.